These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 49326)

  • 61. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 63. Murine erythroblastosis by a novel viral agent.
    Imamura N
    Gan; 1973 Apr; 64(2):121-31. PubMed ID: 4353206
    [No Abstract]   [Full Text] [Related]  

  • 64. Studies of lymphocyte stimulation by intact tumor-cell and solubilized tumor antigen.
    Dean JH; McCoy JL; Lewis D; Appella E; Law LW
    Int J Cancer; 1975 Sep; 16(3):465-75. PubMed ID: 51834
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Rauscher-MuLV-induced leukemia, RBL-5, bears two tumor-associated transplantation antigens expressed on distinct molecules.
    Galetto G; Law LW; Rogers MJ
    Int J Cancer; 1985 Dec; 36(6):713-9. PubMed ID: 2415471
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between various cell-surface antigens induced by murine leukemia virus in the rat: serological analysis.
    Kuzumaki N
    Hokkaido Igaku Zasshi; 1975 May; 50(3):304-10. PubMed ID: 172420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor-specific and tumor-associated membrane antigens of Rous sarcoma virus transformed hamster fibroblasts.
    Comoglio PM; Bertini M; Prat M
    Int J Cancer; 1978 Jul; 22(1):55-62. PubMed ID: 79559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative behavior of simian virus 40 T-antigen and of tumor-specific surface and transplantation antigens during partial purification.
    Luborsky SW; Chang C; Pancake SJ; Mora PT
    Cancer Res; 1978 Aug; 38(8):2367-71. PubMed ID: 78758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 75. Increase in cell surface antigen expression by leukemic cells following in vitro treatment with papain.
    Coudert A; Dore JF; Huchet R; Guibout C; Santana C
    Eur J Cancer (1965); 1976 Jun; 12(6):475-9. PubMed ID: 954558
    [No Abstract]   [Full Text] [Related]  

  • 76. Immune response to Rauscher virus-induced leukemia in DBA mice. II. Correlation between antigenic expression and pathogenesis.
    Tóth FD; Váczi L
    Neoplasma; 1978; 25(3):265-72. PubMed ID: 79984
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 78. Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.
    Risser R; Stockert E; Old LJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3918-22. PubMed ID: 211509
    [TBL] [Abstract][Full Text] [Related]  

  • 79. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
    Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
    J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
    [No Abstract]   [Full Text] [Related]  

  • 80. Studies of the leukemic cell associated antigen(s) in mice with myeloid leukemia (Graffi), using the immunoperoxidase techniques.
    Yantchev IK
    Neoplasma; 1979; 26(4):397-404. PubMed ID: 230420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.